AI and Precision Medicine in Cancer Management
暫譯: 癌症管理中的人工智慧與精準醫療
Chen, Jen-Tsung
- 出版商: CRC
- 出版日期: 2026-05-29
- 售價: $3,610
- 貴賓價: 9.5 折 $3,429
- 語言: 英文
- 頁數: 214
- 裝訂: Quality Paper - also called trade paper
- ISBN: 1041112041
- ISBN-13: 9781041112044
-
相關分類:
DeepLearning、Machine Learning、Maker
尚未上市，無法訂購
相關主題
商品描述
This book presents advancements of artificial intelligence (AI)-based technologies and digital omics, highlighting their applications in developing sustainable healthcare and precision medicine for managing diverse cancers. It presents cutting-edge AI tools, machine and deep learning models, and generative AI, integrated with IoT and robotics to assist in cancer management involving prediction and prevention, diagnosis, drug discovery, drug design and development, smart healthcare, personalized medicine, and pharmacology. This book supports global public health and contributes to the goal of establishing "Good Health and Well-Being," one of "The Sustainable Development Goals (SDGs) 2030.
Key Features:
- Provides AI/omics-driven precision medicine and sustainable management of cancers.
- Summarizes AI-driven drug and vaccine developments with AI tools for infectious disease prevention for clinicians, researchers and policy makers.
- Proposes AI-based strategies for disease prediction, surveillance, and diagnosis.
商品描述(中文翻譯)
這本書介紹了基於人工智慧（AI）技術和數位組學的進展，強調它們在開發可持續醫療保健和精準醫學以管理各種癌症方面的應用。書中展示了尖端的AI工具、機器學習和深度學習模型，以及生成式AI，這些技術與物聯網（IoT）和機器人技術相結合，以協助癌症管理，包括預測和預防、診斷、藥物發現、藥物設計與開發、智慧醫療、個人化醫學和藥理學。本書支持全球公共衛生，並為實現「良好健康與福祉」的目標做出貢獻，這是「2030年可持續發展目標（SDGs）」之一。
主要特色：
- 提供基於AI/組學的精準醫學和癌症的可持續管理。
- 總結了基於AI的藥物和疫苗開發，並為臨床醫生、研究人員和政策制定者提供了針對傳染病預防的AI工具。
- 提出基於AI的疾病預測、監測和診斷策略。
作者簡介
Dr. Jen-Tsung Chen is a professor of cell biology at the National University of Kaohsiung in Taiwan. He teaches cell biology, genomics, proteomics, plant physiology, and plant biotechnology. Dr. Chen's research interests include bioactive compounds, chromatography techniques, plant molecular biology, plant biotechnology, bioinformatics, and systems pharmacology. He is an active editor of academic books and international journals to advance the exploration of multidisciplinary knowledge involving plant physiology, plant biotechnology, nanotechnology, materials science, ethnopharmacology, and systems biology. He serves as an associate editor, editorial board member, and guest editor in reputed journals. Dr. Chen published books in collaboration with international publishers, and he is handling book projects on diverse topics such as AI technologies, drug discovery, drug development, herbal medicine, medicinal biotechnology, nanotechnology, bioengineering, plant functional genomics, plant speed breeding, epigenetics, functional RNAs, and CRISPR-based genome editing. Dr. Chen is a productive author in academic publications and was recognized as one of the World's Top 2% Scientists 2023, 2024, and 2025 by Elsevier and Stanford University. In 2025, Dr. Chen received the Springer Nature Editor of Distinction Award.
作者簡介(中文翻譯)
陳仁宗博士是台灣高雄大學的細胞生物學教授。他教授細胞生物學、基因組學、蛋白質組學、植物生理學和植物生物技術。陳博士的研究興趣包括生物活性化合物、色譜技術、植物分子生物學、植物生物技術、生物資訊學和系統藥理學。他積極擔任學術書籍和國際期刊的編輯，以促進涉及植物生理學、植物生物技術、納米技術、材料科學、民族藥理學和系統生物學的多學科知識探索。他在知名期刊中擔任副編輯、編輯委員會成員和客座編輯。陳博士與國際出版商合作出版書籍，並正在處理多樣主題的書籍專案，如人工智慧技術、藥物發現、藥物開發、中草藥、醫藥生物技術、納米技術、生物工程、植物功能基因組學、植物快速育種、表觀遺傳學、功能性RNA和基於CRISPR的基因組編輯。陳博士在學術出版物中是高產的作者，並於2023年、2024年和2025年被Elsevier和史丹佛大學認定為全球前2%的科學家。在2025年，陳博士獲得Springer Nature卓越編輯獎。
